TOPCAT: Spironolactone cuts hospitalizations for diastolic heart failure Family Practice News Digital Network DALLAS – Spironolactone did not hit a home run in the large international "treatment of preserved cardiac function heart failure with an aldosterone antagonist" (TOPCAT) trial, but it did knock out a solid single in the form of significantly reduced ... |
